Who Paid My Doc
Adam Mecca
Psychiatry New Haven, CT Medical Doctor
NPI 1033485263 CMS profile 2131046
20 York St, T-209, Yale New Haven Hospital, New Haven, CT 06510
General payments
$6,015
Research payments
$1,207
Ownership & investment interest
$0
Research they led as principal investigator
$5,072,256
Through program year 2025, Adam Mecca of New Haven, CT is reported in the CMS Open Payments database as having received $6,015 across 12 general payments and $1,207 in research payments paid to them. Separately, studies naming them as principal investigator received $5,072,256 in research payments, paid to institutions rather than to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.
General payments for this record sit in the 91st percentile of Psychiatry profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
5 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $1,339 | 10 | |
| 2024 | General | $4,600 | 1 | |
| 2023 | Research | $388 | 1 | |
| 2022 | Research | $819 | 1 | |
| 2019 | General | $76 | 1 |
Beside peers
- Adam Mecca
- Psychiatry median
- Middle half of Psychiatry
- National median
In program year 2025, general payments to Adam Mecca were reported at $1,339. Among 14,155 Psychiatry profiles paid that year, the median was $180 and the middle half received between $58 and $685.
Show as a table
| Year | Adam Mecca | Psychiatry median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $76 | $184 | $59–$605 | $163 |
| 2020 | $0 | $119 | $36–$372 | $114 |
| 2021 | $0 | $143 | $43–$576 | $132 |
| 2022 | $0 | $153 | $50–$590 | $149 |
| 2023 | $0 | $170 | $56–$651 | $160 |
| 2024 | $4,600 | $179 | $57–$673 | $164 |
| 2025 | $1,339 | $180 | $58–$685 | $169 |
Breakdown
Prescribing to Medicare patients
Part D · data year 2024 · 9 drugsPart D claims
336
Drug cost
$3,805
Branded share of claims
0%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Donepezil Hcl | Generic | 129 | $1,235 | |
| Escitalopram Oxalate | Generic | 91 | $971 | |
| Mirtazapine | Generic | 14 | $712 | |
| Memantine Hcl | Generic | 36 | $469 | |
| Quetiapine Fumarate | Generic | 16 | $196 | |
| Sertraline Hcl | Generic | 12 | $124 | |
| Clonazepam | Generic | 12 | $85 | |
| Buspirone Hcl | Generic | 11 | $7 | |
| Lorazepam | Generic | 15 | $6 |
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 158 Part D prescribers listed as Geriatric Psychiatry; they describe a distribution and say nothing about conduct.
Billing to Medicare
Part B · data year 2024 · 3 billing codesPaid by Medicare
$5,347
Medicare patients
29
Services billed
74
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| Alzheimer's or dementia | 75% | |
| High blood pressure | 59% | |
| Arthritis | 48% |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
14 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Psychiatry in Connecticut
Related records
Psychiatry in Connecticut
Practitioners in the same specialty and state, ranked by reported value.
All Psychiatry
Everyone recorded under this specialty, nationwide.
Doctors in Connecticut
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.